London, United Kingdom

Maneesh Sahani

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Babylon Partners Limited. Active years: 2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maneesh Sahani: Innovator in Medical Diagnosis Technology

Introduction

Maneesh Sahani is a notable inventor based in London, GB. He has made significant contributions to the field of medical technology, particularly in the area of computer-implemented medical diagnosis. With a total of 2 patents, his work is paving the way for advancements in healthcare solutions.

Latest Patents

Maneesh's latest patents focus on methods for providing a computer-implemented medical diagnosis. One of the key aspects of his invention includes receiving input from a user that comprises at least one symptom. This input is then processed through a medical model to derive estimates of the probability of the user having a disease. The method involves inputting these estimates into an inference engine, performing approximate inference on a probabilistic graphical model, and ultimately outputting the probability of the user having the disease for display on a device.

Career Highlights

Maneesh is currently employed at Babylon Partners Limited, where he continues to innovate in the medical technology sector. His work is instrumental in developing systems that enhance the accuracy and efficiency of medical diagnoses.

Collaborations

Maneesh collaborates with talented individuals such as Adam Philip Baker and Iurii Perov, contributing to a dynamic work environment that fosters innovation.

Conclusion

Maneesh Sahani's contributions to medical diagnosis technology exemplify the impact of innovative thinking in healthcare. His patents and ongoing work at Babylon Partners Limited are set to transform how medical diagnoses are approached in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…